Inicio>>Signaling Pathways>> Others>> Estrogen Receptor/ERR>>Mestranol

Mestranol (Synonyms: EE 3-ME, Ethynyl Estradiol 3-methyl ether, NSC 84032, SC-475, Δ-MVE)

Catalog No.GC13477

El mestranol es un profÁrmaco inactivo y se vuelve biolÓgicamente activo al convertirse en etinilestradiol (EE).

Products are for research use only. Not for human use. We do not sell to patients.

Mestranol Chemical Structure

Cas No.: 72-33-3

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
37,00 $
Disponible
100mg
35,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Mestranol is the 3-methyl ether of ethinylestradiol. It was the estrogen used in many of the first oral contraceptives.Target: Estrogen Receptor/ERRMestranol is absorbed very rapidly from the digestive tract and maximum plasma levels are attained in 1-4 hours, the majority at 1-2 hours. Detectable levels of mestranol are present 24 hours postingestion in 58% of subjects after a 50 μg dose and in 79% after a 100 μg dose. At all dose levels, highest plasma mestranol levels and area under the curve of plasma levels (AUC) occurred in Sri Lankan women, and lowest plasma levels in Nigerian women, even when corrected for body surface differences [1].

References:
[1]. Goldzieher, J.W., T.S. Dozier, and A. de la Pena, Plasma levels and pharmacokinetics of ethynyl estrogens in various populations: II. Mestranol. Contraception, 1980. 21(1): p. 17-27.

Reseñas

Review for Mestranol

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Mestranol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.